Jared Gollob serves as Executive at Kymera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jared Gollob has executed 56 insider transactions totaling $19.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 24, 2021 involved selling 8,675 shares valued at $441.6K.
Jared Gollob currently holds 159,299 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jared Gollob has been a net seller of KYMR stock. They have purchased $0 and sold $19.5M worth of shares.
Jared Gollob's most recent insider trade was on Feb 24, 2021, when they sold 8,675 shares at $50.91 per share.
Get notified when new Form 4 filings are submitted
| $49.65 |
| Discretionary |
| Feb 22, 2021 | KYMR | $479.1K | Sale | 9,104 | $52.63 | Discretionary |
| Feb 19, 2021 | KYMR | $489.6K | Sale | 8,887 | $55.09 | Discretionary |
| Feb 18, 2021 | KYMR | $363.6K | Sale | 6,499 | $55.94 | Discretionary |
| Feb 17, 2021 | KYMR | $440.8K | Sale | 7,550 | $58.39 | Discretionary |